RxDoctor Payments Data

Steven Joe, DO

Family Medicine · Orange, CANPI 1649366410

Payments from drug & device makers

$805in general payments, 2019–2025

Across 39 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Collegium Pharmaceutical, Inc.$237
  • Novo Nordisk$114
  • Pfizer$113
  • Amgen$66
  • AstraZeneca$58
  • GSK$53
  • plus $164 from 7 others

What the payments were for

  • Consulting fees$121%
  • Food & beverage$79499%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$805 in reported general payments places this provider in the 70th percentile of 10,533 family medicine providers in California.

See all family medicine providers in California

Medicare billing

Part B allowed, 2024
$45,624
Medicare patients
118
Services billed
2,984

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide71$75,536
JardianceEmpagliflozin46$55,018
FarxigaDapagliflozin Propanediol33$45,006
TrulicityDulaglutide31$39,968
EliquisApixaban29$33,373
Breo ElliptaFluticasone/Vilanterol28$19,832
JanuviaSitagliptin Phosphate18$17,210
Atorvastatin Calcium455$5,246
Testosterone24$5,003
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,413
Wixela InhubFluticasone Propion/Salmeterol25$3,002
Losartan Potassium251$2,717
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen117$2,350
Levothyroxine Sodium146$2,059
Bupropion XlBupropion Hcl72$2,049

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$114$75,53671 claims
AstraZenecaFarxiga$58$45,00633 claims
Lilly USA, LLCTrulicity$26$39,96831 claims
PfizerEliquis$113$33,37329 claims
GSKBreo Ellipta$53$19,83228 claims
MerckJanuvia$21$17,21018 claims
AbbVieSynthroid$20$1,99525 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 10,533 family medicine providers in California.

Other family medicine in Orange

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →